XTNT · Xtant Medical Holdings, Inc. · Webcasts, Transcripts & Audio
$0.26
-0.01 (-4.20%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$38.12M
Shares
140.29M
Volume · Nov 13
181.75K
Avg daily vol (3M)
1.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Xtant Medical Holdings, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Xtant Medical Holdings, Inc. (XTNT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-11
Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript
Balanced tone
Hemoblast/Dillon Distribution Integration
Sales Force Expansion
Liquidity and Capital Structure
Revenue
$23.03M
▼ 35% YoY Diluted EPS
$-0.07
▼ 450% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
Confident tone
Trivium Shaped product launch
Companion Spine divestiture and balance sheet
Amnio and advanced wound care headwinds
Revenue
$20.88M
▼ 36.5% YoY Diluted EPS
$-0.02
Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
Positive tone
Companion Spine divestiture and strategic refocus
Hardware segment outlook
Self-sustainability and financial discipline
Revenue
$32.36M*
▲ 2.7% YoY Gross margin
54.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
Confident tone
Self-sustainability and cash generation
Amniotic membrane reimbursement landscape
New product launches and innovation
Revenue
$33.26M
▲ 19% YoY Diluted EPS
$0.01
Gross margin
66.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
Confident tone
Biologics growth and new product launches
Sale of non-core COFLEX/Paradigm OUS assets
Gross margin outlook
Revenue
$35.41M
▲ 18.3% YoY Diluted EPS
$0.02
Gross margin
68.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript
Confident tone
Biologics vertical integration and new product launches
Revenue growth and guidance
Cost-cutting and profitability
Revenue
$32.90M
▲ 18% YoY Diluted EPS
$0.00
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-06
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript
Positive tone
Gross margin pressure
Biologics business and vertical integration
Cost-cutting and self-sustainability
Revenue
$31.51M*
▲ 12.1% YoY Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Call Transcript
Confident tone
New Product Launches
Profitability and Adjusted EBITDA
In-House Biologics Manufacturing
Revenue
$27.94M
▲ 11.7% YoY Diluted EPS
$-0.04
▼ 157.1% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call
Revenue
$29.94M
▲ 48% YoY Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Xtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript
Confident tone
Distribution & Contract Access
Profitability & Gross Margin
New Product Introductions
Revenue
$27.87M
▲ 55.3% YoY Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-04-01
Xtant Medical Holdings, Inc. (XTNT) Q4 2023 Earnings Call Transcript
Confident tone
Surgalign acquisition and supply chain
Gross margin and product mix
2024 revenue guidance and organic growth
Revenue
$28.11M*
▲ 84.1% YoY Gross margin
61.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Xtant Medical Holdings, Inc. (XTNT) Q3 2023 Earnings Call Transcript
Revenue
$25.02M
▲ 73% YoY Diluted EPS
$0.07
Gross margin
61.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Xtant Medical Holdings, Inc. (XTNT) Q2 2023 Earnings Call Transcript
Revenue
$20.23M
▲ 32.4% YoY Diluted EPS
$-0.02
Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Xtant Medical Holdings, Inc. (XTNT) Q1 2023 Earnings Call Transcript
Revenue
$17.94M
▲ 38.5% YoY Diluted EPS
$-0.02
Gross margin
58.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Xtant Medical Holdings, Inc. (XTNT) Q4 2022 Earnings Call Transcript
Revenue
$15.27M*
▲ 9.3% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Xtant Medical Holdings, Inc. (XTNT) Q3 2022 Earnings Call Transcript
Revenue
$14.46M
▲ 5% YoY Diluted EPS
$-0.03
Gross margin
54.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Xtant Medical Holdings, Inc. (XTNT) Q2 2022 Earnings Call Transcript
Revenue
$15.28M
▲ 2% YoY Diluted EPS
$-0.02
Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Xtant Medical Holdings, Inc. (XTNT) Q1 2022 Earnings Call Transcript
Revenue
$12.96M
▲ 3.3% YoY Diluted EPS
$-0.03
Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Xtant Medical Holdings, Inc. (XTNT) Q4 2021 Earnings Call
Revenue
$13.97M*
▼ 0.3% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Xtant Medical Holdings, Inc. (XTNT) Q3 2021 Earnings Call
Revenue
$13.78M
▼ 1.7% YoY Diluted EPS
$-0.02
Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Xtant Medical Holdings, Inc. (XTNT) Q2 2021 Earnings Call
Revenue
$14.97M
▲ 42.2% YoY Diluted EPS
$-0.01
Gross margin
63.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Xtant Medical Holdings, Inc. (XTNT) Q1 2021 Earnings Call
Revenue
$12.54M
▼ 15.1% YoY Diluted EPS
$0.00
Gross margin
64.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Xtant Medical Holdings, Inc. (XTNT) Q4 2020 Earnings Call Transcript
Revenue
$14.02M*
▼ 17.4% YoY Gross margin
64.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-01
Xtant Medical Holdings, Inc. (XTNT) Q3 2020 Earnings Call Transcript
Revenue
$14.02M
▼ 10.8% YoY Diluted EPS
$-0.10
Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Xtant Medical Holdings, Inc. (XTNT) Q2 2020 Earnings Call Transcript
Revenue
$10.53M
▼ 31.1% YoY Diluted EPS
$-0.19
Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Xtant Medical Holdings, Inc. (XTNT) Q1 2020 Earnings Call Transcript
Revenue
$14.78M
▼ 11.7% YoY Diluted EPS
$-0.19
Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Xtant Medical Holdings, Inc. (XTNT) Q4 2019 Earnings Call
Revenue
$16.96M*
▼ 7.1% YoY Gross margin
67.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts
Key facts
CIK
1453593
CUSIP
98420P308
13F (30d)
29 filings
23 filers
Visit website
Investor relations